Skip navigation

Refine by Type

Results 1 - 10 of 63 for IMATINIB
  1. Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers of the blood cells. Imatinib is also used to treat gastrointestinal stromal tumors ( ...
  2. ... with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal ...
  3. ... whose disease could not be treated successfully with imatinib (Gleevec) or people who cannot take imatinib. Nilotinib is in a class of medications called ...
  4. CML Guide: Information for Patients and Caregivers (Leukemia & Lymphoma Society) - PDF  
    ... and to measure the results of treatment. Gleevec® (imatinib mesylate). A type of drug called a tyrosine ...
  5. ... longer benefit from other medications for leukemia including imatinib (Gleevec) or who cannot take these medications because ...
  6. ... with oral tyrosine kinase inhibitors (TKIs) such as imatinib (brand name: Gleevec), dasatinib (brand name: Sprycel), or ... hypericum perforatum). Grapefruit juice should also be avoided. Imatinib (brand name: Gleevec) — Imatinib mesylate is a TKI ...
  7. Treating Chronic Myeloid Leukemia by Phase (American Cancer Society)  
    ... is a tyrosine kinase inhibitor (TKI) such as imatinib (Gleevec), nilotinib (Tasigna), or dasatinib (Sprycel). For imatinib, the usual starting dose is 400 mg per ...
  8. ... these factors, adjuvant treatment with the targeted drug imatinib (Gleevec) is typically recommended for at least a ... recommend giving patients at least 3 years of imatinib. For some very small tumors (less than 2 ...
  9. ... with this combination.Talk with your health provider.Imatinib (Gleevec)The body breaks down imatinib (Gleevec) to get rid of it. St. John's ... increase how quickly the body gets rid of imatinib (Gleevec). Taking St. John's wort along with imatinib ( ...
  10. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... potential targets for targeted cancer therapies. For example, imatinib mesylate (Gleevec®) targets the BCR-ABL fusion protein , ... Avastin®) , ziv-aflibercept (Zaltrap®) , regorafenib ... (Gleevec®) Endocrine/neuroendocrine tumors: Lanreotide acetate (Somatuline® ...
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · next